MicroRNA-145 post-transcriptionally regulates the expression and function of P-glycoprotein in intestinal epithelial cells

Molecular Pharmacology

Volumn 83, Issue 2, 2013, Pages 399-405

  Ikemura, Kenji ^a   Yamamoto, Misato ^c   Miyazaki, Saori ^a   Mizutani, Hideki ^a   Iwamoto, Takuya ^b,c   Okuda, Masahiro ^b,c  

^a KINJO GAKUIN UNIVERSITY   (Japan)

^b MIE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MIE UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MESSENGER RNA; MICRORNA 145; MULTIDRUG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 1A; RHODAMINE 123; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL STRAIN CACO 2; CELL STRAIN HEK293; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; INTESTINE EPITHELIUM CELL; LIVER INJURY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE BINDING SITE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN RNA BINDING; RAT; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION INJURY; REPORTER GENE; SMALL INTESTINE; TRANSCRIPTION REGULATION;

3' UNTRANSLATED REGIONS; ANIMALS; BASE SEQUENCE; CACO-2 CELLS; CELL LINE; CELL LINE, TUMOR; DOWN-REGULATION; EPITHELIAL CELLS; HEK293 CELLS; HUMANS; INTESTINES; LIVER; MALE; MICRORNAS; MOLECULAR SEQUENCE DATA; P-GLYCOPROTEIN; P-GLYCOPROTEINS; RATS; RATS, WISTAR; REPERFUSION INJURY; RNA PROCESSING, POST-TRANSCRIPTIONAL; RNA, MESSENGER;

EID: 84872745556     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.112.081844     Document Type: Article

References (44)

1. Bao L, Hazari S, Mehra S, Kaushal D, Moroz K, and Dash S (2012) Increased expression of P-glycoprotein and doxorubicin chemoresistance of metastatic breast cancer is regulated by miR-298. Am J Pathol 180:2490-2503.
2. Betel D, Wilson M, Gabow A, Marks DS, and Sander C (2008) The microRNA.org resource: targets and expression. Nucleic Acids Res 36 (Database issue): D149-D153.
3. Bourguignon LY, Spevak CC, Wong G, Xia W, and Gilad E (2009) Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotherapy resistance in breast tumor cells. J Biol Chem 284:26533-26546.
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
5. Brady JM, Cherrington NJ, Hartley DP, Buist SC, Li N, and Klaassen CD (2002) Tissue distribution and chemical induction of multiple drug resistance genes in rats. Drug Metab Dispos 30:838-844.
6. Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, and Croce CM et al. (2008) Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47:897-907.
7. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, and Beretta L (2011) Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS ONE 6:e23937.
8. Cheng Y, Liu X, Yang J, Lin Y, Xu DZ, Lu Q, Deitch EA, Huo Y, Delphin ES, and Zhang C (2009) MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation. Circ Res 105:158-166.
9. Cordon-Cardo C, O'Brien JP, Boccia J, Casals D, Bertino JR, and Melamed MR (1990) Expression of the multidrug resistance gene product (P-glycoprotein) in human normal and tumor tissues. J Histochem Cytochem 38:1277-1287.
10. Dalmasso G, Nguyen HT, Yan Y, Laroui H, Charania MA, Obertone TS, Sitaraman SV, and Merlin D (2011) MicroRNA-92b regulates expression of the oligopeptide transporter PepT1 in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol 300:G52-G59.
11. Dharap A, Bowen K, Place R, Li LC, and Vemuganti R (2009) Transient focal ischemia induces extensive temporal changes in rat cerebral microRNAome. J Cereb Blood Flow Metab 29:675-687.
12. Eulalio A, Huntzinger E, and Izaurralde E (2008) Getting to the root of miRNA-mediated gene silencing. Cell 132:9-14.
13. Filipowicz W, Bhattacharyya SN, and Sonenberg N (2008) Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight? Nat Rev Genet 9:102-114.
14. Goto M, Masuda S, Saito H, and Inui K (2003) Decreased expression of P-glycoprotein during differentiation in the human intestinal cell line Caco-2. Biochem Pharmacol 66:163-170.
15. Gottesman MM, Fojo T, and Bates SE (2002) Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2:48-58.
16. Iio A, Nakagawa Y, Hirata I, Naoe T, and Akao Y (2010) Identification of non-coding RNAs embracing microRNA-143/145 cluster. Mol Cancer 9:136.
17. Ikemura K, Inoue K, Mizutani H, Oka H, Iwamoto T, and Okuda M (2012) An an-tioxidant Trolox restores decreased oral absorption of cyclosporine A after liver ischemia-reperfusion through distinct mechanisms between CYP3A and P-glycoprotein in the small intestine. Eur J Pharmacol 690:192-201.
18. Ikemura K, Urano K, Matsuda H, Mizutani H, Iwamoto T, and Okuda M (2009) Decreased oral absorption of cyclosporine A after liver ischemia-reperfusion injury in rats: the contribution of CYP3A and P-glycoprotein to the first-pass metabolism in intestinal epithelial cells. J Pharmacol Exp Ther 328:249-255.
19. Jin M, Shimada T, Yokogawa K, Nomura M, Ishizaki J, Piao Y, Kato Y, Tsuji A, and Miyamoto K (2006) Site-dependent contributions of P-glycoprotein and CYP3A to cyclosporin A absorption, and effect of dexamethasone in small intestine of mice. Biochem Pharmacol 72:1042-1050.
20. Kamisako T, Leier I, Cui Y, König J, Buchholz U, Hummel-Eisenbeiss J, and Keppler D (1999) Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2. Hepatology 30: 485-490.
21. Kim VN (2005) MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol 6:376-385.
22. Kimchi-Sarfaty C, Oh JM, Kim IW, Sauna ZE, Calcagno AM, Ambudkar SV, and Gottesman MM (2007) A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science 315:525-528.
23. Lee EJ, Baek M, Gusev Y, Brackett DJ, Nuovo GJ, and Schmittgen TD (2008) Systematic evaluation of microRNA processing patterns in tissues, cell lines, and tumors. RNA 14:35-42.
24. Li Z, Hu S, Wang J, Cai J, Xiao L, Yu L, and Wang Z (2010) MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells. Gynecol Oncol 119:125-130.
25. Lin Y, Liu X, Cheng Y, Yang J, Huo Y, and Zhang C (2009) Involvement of Micro-RNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells. J Biol Chem 284:7903-7913.
26. Loor F, Tiberghien F, Wenandy T, Didier A, and Traber R (2002) Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpep-tide receptor. J Med Chem 45:4613-4628.
27. Masuda S and Inui K (2006) An up-date review on individualized dosage adjustment of calcineurin inhibitors in organ transplant patients. Pharmacol Ther 112: 184-198.
28. Matsson P, Pedersen JM, Norinder U, Bergström CA, and Artursson P (2009) Identification of novel specific and general inhibitors of the three major human ATP-binding cassette transporters P-gp, BCRP and MRP2 among registered drugs. Pharm Res 26:1816-1831.
29. Nakajima M and Yokoi T (2011) MicroRNAs from biology to future pharmacotherapy: regulation of cytochrome P450s and nuclear receptors. Pharmacol Ther 131: 330-337.
30. Omae T, Goto M, Shimomura M, Masuda S, Ito K, Okuda M, and Inui K (2005) Transient up-regulation of P-glycoprotein reduces tacrolimus absorption after ischemia-reperfusion injury in rat ileum. Biochem Pharmacol 69:561-568.
31. Pan YZ, Morris ME, and Yu AM (2009) MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells. Mol Pharmacol 75:1374-1379.
32. Schinkel AH, Mayer U, Wagenaar E, Mol CA, van Deemter L, Smit JJ, van der Valk MA, Voordouw AC, Spits H, and van Tellingen O et al. (1997) Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glyco-proteins. Proc Natl Acad Sci USA 94:4028-4033.
33. Schwab M, Eichelbaum M, and Fromm MF (2003) Genetic polymorphisms of the human MDR1 drug transporter. Annu Rev Pharmacol Toxicol 43:285-307.
34. Shimomura M, Masuda S, Saito H, Sakamoto S, Uemoto S, Tanaka K, and Inui K (2002) Roles of the jejunum and ileum in the first-pass effect as absorptive barriers for orally administered tacrolimus. J Surg Res 103:215-222.
35. Takagi S, Nakajima M, Kida K, Yamaura Y, Fukami T, and Yokoi T (2010) MicroRNAs regulate human hepatocyte nuclear factor 4alpha, modulating the expression of metabolic enzymes and cell cycle. J Biol Chem 285:4415-4422.
36. Takagi S, Nakajima M, Mohri T, and Yokoi T (2008) Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4. J Biol Chem 283:9674-9680.
37. Tamura S, Tokunaga Y, Ibuki R, Amidon GL, Sezaki H, and Yamashita S (2003) The site-specific transport and metabolism of tacrolimus in rat small intestine. J Pharmacol Exp Ther 306:310-316.
38. Thörn M, Finnström N, Lundgren S, Rane A, and Lööf L (2005) Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract. Br J Clin Pharmacol 60:54-60.
39. Wang D and Sadée W (2006) Searching for polymorphisms that affect gene expression and mRNA processing: example ABCB1 (MDR1). AAPS J 8: E515-E520.
40. Xin M, Small EM, Sutherland LB, Qi X, McAnally J, Plato CF, Richardson JA, Bassel-Duby R, and Olson EN (2009) MicroRNAs miR-143 and miR-145 modulate cytoskeletal dynamics and responsiveness of smooth muscle cells to injury. Genes Dev 23:2166-2178.
41. Xu CF, Yu CH, and Li YM (2009) Regulation of hepatic microRNA expression in response to ischemic preconditioning following ischemia/reperfusion injury in mice. OMICS 13:513-520.
42. Yamaura Y, Nakajima M, Takagi S, Fukami T, Tsuneyama K, and Yokoi T (2012) Plasma microRNA profiles in rat models of hepatocellular injury, cholestasis, and steatosis. PLoS ONE 7:e30250.
43. Zhu H, Wu H, Liu X, Evans BR, Medina DJ, Liu CG, and Yang JM (2008) Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells. Biochem Pharmacol 76:582-588.
44. Zrieki A, Farinotti R, and Buyse M (2008) Cyclooxygenase inhibitors down regulate P-glycoprotein in human colorectal Caco-2 cell line. Pharm Res 25:1991-2001.